Hemopoietic growth factors: a review - PubMed (original) (raw)
Review
. 1988 Oct 15;48(20):5624-37.
Affiliations
- PMID: 2458827
Review
Hemopoietic growth factors: a review
G Morstyn et al. Cancer Res. 1988.
Abstract
Several hemopoietic growth factors have now been purified, cloned, and produced in bacteria. Granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor are already being used in clinical trials. Within 12 months two more hemopoietic growth factors, macrophage colony stimulating factor (also called colony stimulating factor 1) and interleukin 3 (also called multi-colony stimulating factor) will be used for patient treatment. This review discusses the recent advances in our knowledge of the molecular properties and biological specificities of these factors. It is now clear that these molecules are able to modulate selectively the activity of mature blood cells as well as stimulating the production of specific lineages of blood cells. The availability of recombinant hemopoietic growth factors purified from animal or yeast cell conditioned medium or bacteria has facilitated in vivo experiments, as well as the clinical trials. Each of the growth factors has a unique spectrum of biological activities and it appears that the growth factors will enhance the recovery and function of circulating white blood cells after cancer therapy or bone marrow transplantation.
Similar articles
- Bone marrow failure and hematopoietic growth factors.
Douer D. Douer D. Isr J Med Sci. 1989 Apr;25(4):183-5. Isr J Med Sci. 1989. PMID: 2468629 No abstract available. - [The role of hematopoietic growth factors in the regulation of normal and pathological hematopoiesis].
Welte K. Welte K. Verh Dtsch Ges Pathol. 1990;74:25-7. Verh Dtsch Ges Pathol. 1990. PMID: 1708595 Review. German. - Rationals for the development of the human hematopoietic colony stimulating factors as therapeutical useful drugs.
Krumwieh D, Schulz G, Seiler FR. Krumwieh D, et al. Behring Inst Mitt. 1988 Apr;(82):265-81. Behring Inst Mitt. 1988. PMID: 2457362 Review. - Hemopoietic colony stimulating factors: an overview.
Haeuber D, DiJulio JE. Haeuber D, et al. Oncol Nurs Forum. 1989 Mar-Apr;16(2):247-55. Oncol Nurs Forum. 1989. PMID: 2467263 Review.
Cited by
- In vivo tumor growth enhancement by granulocyte colony-stimulating factor.
Segawa K, Ueno Y, Kataoka T. Segawa K, et al. Jpn J Cancer Res. 1991 Apr;82(4):440-7. doi: 10.1111/j.1349-7006.1991.tb01868.x. Jpn J Cancer Res. 1991. PMID: 1710615 Free PMC article. - Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist.
Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cunha JM, et al. Br J Pharmacol. 2000 Jul;130(6):1418-24. doi: 10.1038/sj.bjp.0703434. Br J Pharmacol. 2000. PMID: 10903985 Free PMC article. - Inhibitory effect of Korean Red Ginseng on melanocyte proliferation and its possible implication in GM-CSF mediated signaling.
Oh CT, Park JI, Jung YR, Joo YA, Shin DH, Cho HJ, Ahn SM, Lim YH, Park CK, Hwang JS. Oh CT, et al. J Ginseng Res. 2013 Oct;37(4):389-400. doi: 10.5142/jgr.2013.37.389. J Ginseng Res. 2013. PMID: 24235857 Free PMC article. - Arachidonic acid metabolism in TNS-induced chronic and immunologic enteritis in rats, and the effect of 5-ASA.
Zijlstra FJ, Dijk AP, Selve N, Wilson JH. Zijlstra FJ, et al. Mediators Inflamm. 1993;2(5):391-5. doi: 10.1155/S0962935193000559. Mediators Inflamm. 1993. PMID: 18475551 Free PMC article. - Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR).
Xu JW, Konttinen YT, Waris V, Pätiälä H, Sorsa T, Santavirta S. Xu JW, et al. Clin Rheumatol. 1997 May;16(3):243-8. doi: 10.1007/BF02238958. Clin Rheumatol. 1997. PMID: 9184260 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials